News
Stay up-to-date on current women’s health news, articles and videos from Speaking of Women's Health, as well as developments from other women’s health news outlets.
Elagolix: A new treatment for pelvic pain caused by endometriosis
Two doses of elagolix are now FDA approved for treatment of pelvic pain caused by endometriosis. These two doses allow clinicians to opt for gentle (150 mg once daily) or strong (200 mg twice daily)…
Dr. Holly L. Thacker Featured in Latest Menopause e-Consult Issue
The North American Menopause Society's November 2018 issue of Menopause e-Consult features expert commentary by Speaking of Women's Health Executive Director Dr. Holly L. Thacker on midlife-related…
FDA Approves ANNOVERA: The First Birth Control Approved As A Vaginal System
TherapeuticsMD announces FDA approval of ANNOVERA™ (segesterone acetate/ethinyl estradiol vaginal system) for birth control. ANNOVERA is the first long-acting prescription birth control that is…
FDA Approves Bijuva: A New Oral Bioidentical Of Estrogen and Progesterone
TherapeuticsMD announces FDA approval of TX-001HR: BIJUVA™ (estradiol and progesterone) capsules for the treatment of moderate to severe vasomotor symptoms due to menopause. BIJUVA is the…
FDA OKs Diagnostic Blood Test to Help Determine Menopausal Status
The US Food and Drug Administration (FDA) has approved Ansh Labs' PicoAMH Elisa diagnostic test to help determine a woman's menopausal status. The PicoAMH Elisa test measures anti-Müllerian hormone…
FDA Approves Single-Dose Treatment For Flu
The first new flu drug in 20 years won approval Wednesday from the Food and Drug Administration. The new antiviral, generically known as baloxavir marboxil but sold under the brand name Xofluza, is…
American Cancer Society Honors Cleveland Clinic Researcher Charis Eng
Charis Eng, MD, PhD, Founding Chair of Cleveland Clinic’s Genomic Medicine Institute, Founding Director of the Center for Personalized Genetic Healthcare, and internationally recognized leader in the…
Genitourinary syndrome of menopause in breast cancer survivors: Treatments are available
Dr. Holly L. Thacker, Dr. Anna Camille Moreno and Dr. Sabrina K. Sikka discuss the genitourinary syndrome of menopause in breast cancer survivors and the treatments available in the Cleveland Clinic…
FDA Expands Gardasil to Include Adults Up to Age 45
The US Food and Drug Administration on Friday approved the use of a human papillomavirus vaccine called Gardasil 9 for men and women between the ages of 27 and 45. The FDA previously approved the HPV…
NAMS Menopause e-Consult Features Commentary on Midlife-Related Clinical Issues
The North American Menopause Society's September issue of Menopause e-Consult features expert commentary from Dr. Heather Hirsch on midlife-related clinical issues. Dr. Hirsch is a graduate of the…
The techno vagina: The laser and radiofrequency device boom in gynecology
In July 2018, the FDA released a statement of concern reiterating the need for research and randomized clinical trials before energy-based device treatments can be widely accepted, and that they are…
Sexual Function after Treatment for Gynecologic Cancer
Learn how cancer and cancer treatment can affect women’s sexual function and what we can do about it. Hear from a panel of experts, have all your questions answered and meet other women who share…